Development trends for generation of single-chain antibody fragments. - Test2 - elhamkhani - TriplyDB

Development trends for generation of single-chain antibody fragments.

Development trends for generation of single-chain antibody fragments.

http://www.wikidata.org/entity/Q35216785

about

A new age for biomedical applications of Ribosome Inactivating Proteins (RIPs): from bioconjugate to nanoconstructs Anti-ABCG2 scFv antibody of lung adenocarcinoma increases chemosensitivity and induces apoptosis through the activation of mitochondrial pathway.CD20-targeting in B-cell malignancies: novel prospects for antibodies and combination therapies.Recent progress in protein-protein interaction study for EGFR-targeted therapeutics.Tumor-targeting domains for chimeric antigen receptor T cells.High-efficiency antibody discovery achieved with multiplexed microscopy.Effects of different interchain linkers on biological activity of an anti-prostate cancer single-chain bispecific antibody Evolution of the magic bullet: Single chain antibody fragments for the targeted delivery of immunomodulatory proteins.Therapeutic Potential of Inorganic Nanoparticles for the Delivery of Monoclonal Antibodies

P2860

Q26738670-53855F0B-5B55-4FCA-9422-0A4D27A58D50 Q36050053-ABE43B4C-7EC2-4E91-A942-C575B59302BA Q38807514-B5FBCEE4-C9DE-4F1C-AB53-E51DAFB17619 Q38899428-A4353313-BE9B-43AE-8D77-BF1249E681E3 Q39045535-76CDAC05-149B-4484-B44B-E468BDF51F81 Q40702389-867AE326-C989-46C4-8E09-EACC3F159ACB Q42423743-B581E29F-E297-49FD-A2A6-22336B5C5719 Q47277628-632E1773-A8A0-4027-98B4-4D320D30F608 Q59113319-FE828D21-2C16-4607-B06F-716B9B7D9114

P2860

Development trends for generation of single-chain antibody fragments.

http://www.wikidata.org/entity/Q35216785

description

2014 nî lūn-bûn

@nan

2014 թուականի Օգոստոսին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի օգոստոսին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Development trends for generation of single-chain antibody fragments.

@ast

Development trends for generation of single-chain antibody fragments.

@en

type

label

Development trends for generation of single-chain antibody fragments.

@ast

Development trends for generation of single-chain antibody fragments.

@en

prefLabel

Development trends for generation of single-chain antibody fragments.

@ast

Development trends for generation of single-chain antibody fragments.

@en

P1433

Q35216785-9A22B429-3306-444F-8DE9-30A96424F05B

P1476

Q35216785-7760ECB0-0381-4C80-9A24-A586370BC80E

P2093

Q35216785-11CCE5B7-4F1D-43AD-BCA3-2593DBE1F56C

Q35216785-4231FFBA-E2D5-430C-AE53-8F6B1BEAC971

Q35216785-A0EADB31-CD40-4582-990F-B1828E4919E4

Q35216785-C47E3D3A-AE0B-4968-B71D-F8BE9C4C8B5A

Q35216785-C53AA495-F985-4E14-AAB0-25FE366D6327

P2860

Q35216785-02B3BAFA-A910-458F-BFD9-6CDA3CBC99A4

Q35216785-0332C539-8987-4FA2-839D-4C8322C9076A

Q35216785-034EE24E-D20F-4720-9BA6-E69203A38510

Q35216785-083DDE6A-17AA-4D04-9765-75A2AF77C2FE

Q35216785-0DA7F783-021A-4579-B2CF-FAC034AF588A

Q35216785-0DC4B059-641E-4575-BE28-C5E17EAC6ED9

Q35216785-0FB9CA59-2036-42F9-B8BD-954631C9D77B

Q35216785-10F1257B-6282-4CAA-9BFE-22CAF5D6CCCC

Q35216785-112D779E-D3D3-41A1-B2A9-F7635C4DAB9B

Q35216785-119F8159-BB6D-4B12-8FDD-FFB19C63B893

P304

Q35216785-33F0925F-8C2B-43EE-A42D-8458388ADE77

P31

Q35216785-1949D152-796D-41BA-A04C-B23B4F861484

P356

Q35216785-01499A43-EAF2-4081-ABAD-100BA7812C3D

P433

Q35216785-03F41EE9-6A82-4902-BF80-2FD051FFD0A9

P478

Q35216785-10EBF0DC-E68D-494A-9647-E285F99F44E6

P50

Q35216785-37D08045-30D3-49D5-9093-FA0F84E7A4A4

P577

Q35216785-F720BEF3-49FF-42EC-9C65-EFCEF8FA9D85

P5875

Q35216785-50864BE1-0464-4BC2-B6F7-86E38FA5EE60

P698

Q35216785-F9358977-D6F9-446C-AB99-E5AEA1F70C28

P356

08923973.2014.945126

P1433

Immunopharmacology and Immunotoxicology

P1476

Development trends for generation of single-chain antibody fragments.

@en

P2093

Asghar Tanomand

http://www.w3.org/2001/XMLSchema#string

Kamal Veisi

http://www.w3.org/2001/XMLSchema#string

Leila Rahbarnia

http://www.w3.org/2001/XMLSchema#string

Shiva Ahdi Khosroshahi

http://www.w3.org/2001/XMLSchema#string

Vahideh Ahmadzadeh

http://www.w3.org/2001/XMLSchema#string

P2860

In vitro selection and evolution of functional proteins by using ribosome display

In vitro evolution of single-chain antibodies using mRNA display

Selection of functional human antibodies from retroviral display libraries

Antiferritin VL homodimer binds human spleen ferritin with high specificity

Directed in vitro evolution and crystallographic analysis of a peptide-binding single chain antibody fragment (scFv) with low picomolar affinity

Affinity improvement of a therapeutic antibody to methamphetamine and amphetamine through structure-based antibody engineering

Engineered antibodies

Biotechnological applications for surface-engineered bacteria

Tumor regression in cancer patients by very low doses of a T cell-engaging antibody

Isolation and characterisation of a human-like antibody fragment (scFv) that inactivates VEEV in vitro and in vivo

P304

297-308

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3109/08923973.2014.945126

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

36

http://www.w3.org/2001/XMLSchema#string

P50

P577

2014-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

264431709

http://www.w3.org/2001/XMLSchema#string

P698

25081575

http://www.w3.org/2001/XMLSchema#string